Chemo brain appears to correlate with long-term changes in the brain’s white matter, according to the results of a study published in the Journal of Clinical Oncology. Patients undergoing chemotherapy have long complained of a phenomenon referred to... Continue Reading

The U.S. Food and Drug Administration (FDA) has approved Votrient® (pazopanib) for the treatment of patients with advanced soft tissue sarcoma (STS) who have received prior chemotherapy. It is the first new drug in decades to treat this type of cancer. Soft... Continue Reading

Inadequate pain treatment is a common and significant problem among cancer patients and the odds for under-treatment are twice as high for minorities, according to the results of a study published in the Journal of Clinical Oncology. Pain remains one... Continue Reading

Women with dense breasts or a first-degree relative with breast cancer are twice as likely as average-risk women to develop breast cancer in their 40s[1] and these women would benefit from beginning mammography screening at age 40[2], according to the... Continue Reading

Patients age 50-70 with previously untreated acute myeloid leukemia (AML) who are treated with Mylotarg® (gemtuzumab ozogamicin) plus standard chemotherapy appear to live longer than those who are treated with standard chemotherapy alone, according to... Continue Reading

Cancer-related fatigue (CRF) is common after treatment for early stage breast cancer, but new results indicate that the phenomenon fades over time, according to a study published in the Journal of Clinical Oncology. Breast cancer is the most commonly... Continue Reading

Chemotherapy plus radiation reduces the risk of recurrence in muscle-invasive bladder cancer patients by nearly 50% compared to radiation alone, according to the results of a study published in the New England Journal of Medicine.[1] Bladder cancer is... Continue Reading

Patients with early stage kidney cancer who had only the tumor removed experienced better survival rates than those who had the entire kidney removed, according to the results of a study published in the Journal of the American Medical Association.[1] Nearly... Continue Reading

In an analysis of three different types of radiation therapy used to treat localized prostate cancer, intensity-modulated radiation therapy (IMRT) was associated with fewer gastrointestinal side effects and fewer hip fractures, but more erectile dysfunction... Continue Reading

The addition of Avastin (bevacizumab) to the standard chemotherapy regimen for non-small cell lung cancer (NSCLC) did not improve survival rates in patients over age 65 with advanced NSCLC, according to the results of a study published in the Journal... Continue Reading

Minimally-invasive radical prostatectomy (MIRP) proves safer than traditional open surgery—resulting in fewer post-surgical complications, fewer blood transfusions, and shorter hospital stays, according to the results of a study published in European... Continue Reading

Tivozanib (AV-951) was well tolerated and improved median progression-free survival (PFS) in some patients with advanced renal cell carcinoma (RCC), according to the results of a phase II study published in the Journal of Clinical Oncology. More than... Continue Reading